According to a new recommendation from the American Heart Association, children who have been diagnosed with Attention Deficit Hyperactivity Disorder (ADHD), also known as Attention Deficit Disorder (ADD), should be screened for heart problems with an electrocardiogram (EKG) before they are prescribed drugs such as Ritalin.
Drugs used to treat ADHD are stimulants, having the potential to increase both heart rate and blood pressure. In children with heart conditions, ADHD drugs could potentially make them more vulnerable to cardiac arrest and other heart problems. A Food and Drug Administration review of its own FDA databases found reports of 19 sudden deaths in children treated with ADHD drugs and 26 reports of other problems including strokes and rapid heart rates between 1999 and 2003.
The Cleveland Clinic estimates that the annual rate of sudden cardiac deaths among the approximately 2.5 million children in the US who take medication for ADHD is approximately one to two children per 100,000.
Prior to prescribing ADHD medication, the AHA now recommends that doctors screen children for any personal or family history of heart problems, and perform a thorough heart exam including an EKG. The AHA also recommends testing for children already taking ADHD drugs. Such testing can help identify any previously undiagnosed heart issues and detect abnormal heart rhythms that may lead to a sudden heart attack.
ADHD medications now have labels to warn patients of the possible risks to individuals who have heart defects or other heart problems.
Questions your doctor should ask in a heart screening exam:
- Has your child ever fainted during exercise or similar physical activity?